General
Preferred name
eslicarbazepine
Synonyms
S-licarbazepine ()
BIA 2-194 ()
Erelib ()
CGP-13751 ()
Stedesa ()
BIA-2-194 ()
Licarbazepine, (s)- ()
(s)-licarbazepine ()
Pazzul ()
P&D ID
PD050683
CAS
104746-04-5
Tags
natural product
drug
available
Drug Status
approved
Drug indication
Seizure disorder
Partial seizures
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Eslicarbazepine is an anticonvulsant. The PubChem CID for eslicarbazepine acetate is CID 179344.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
25
Molecular Weight
254.11
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
3
Aromatic Ring Count
2
cLogP
2.49
TPSA
66.56
Fraction CSP3
0.13
Chiral centers
1.0
Largest ring
7.0
QED
0.76
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Therapeutic Class
Neurology Agents
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Target
Beta-secretase
Sodium Channel
Source data
